Clinical Trial Update: Confirmatory Study of BK1310 in Healthy Infants [Phase 3]

View source ↗

Summary

A Phase 3 confirmatory trial of BK1310 in healthy infants evaluating protection against tetanus, diphtheria, pertussis, poliomyelitis, and bacterial meningitis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Meningitis
• Diphtheria
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• BK1310

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Tetanus, Diphtheria | Phase 3 | Status: COMPLETED | Results posted: 2025-01-06